WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2'6201 Infant (under 12 months) mortality rate: 462
GDP / capita (US$): 1'8551 Child (under 5 years) mortality rate: 602

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 102  101  99  98  96  83  71  55 
Births
Surviving infants
Pop. less than 5 years 11  11  11  11  11  12  11 
Pop. less than 15 years 33  33  33  33  33  33  29  22 
Female 15-49 years 28  27  27  26  26  21  17  13 

Number of reported case

(Click for retrospective incidence data for Kiribati)
Diphtheria
Japanese encephalitis
Measles 30  170 
Mumps
Pertussis 830  161 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kiribati)
Vaccine year result method % card seen                                                
BCG          86  95  86  87  76  80  93  66 
DTP1          95  94  99*  90  90  95 
DTP3          95  94  99  91  86  90  97  43 
HepB_BD          84  82  66  63  52  80 
HepB3          95  94  95  91  86  90  73 
Hib3          95  94  95  91  86 
JapEnc         
MCV          91  91  90  89  82  80  75 
MCV2          84  61  21  35 
PCV1          62 
PCV3          40 
Pol3          91  92  95  95  84  90  97  10 
Rota1         
Rota_last         
Rubella1          91  91  90 
TT2plus          83  100  83  79  50  54 
PAB         
VAD1          76  100  58  77 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kiribati)
BCG 86  95  86  87  76  80  93  66 
DTP1 95  94  99  97  90  95  98  68 
DTP3 95  94  99  91  86  90  97  43 
HepB3 95  94  95  91  86  90  73 
HepB_BD 84  82  66  63  52  80 
Hib3 95  94  95  91  86 
MCV 91  91  90  89  82  80  75 
MCV2 84  61  21  35 
PCV3
Pol3 91  92  95  95  84  90  97  10 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
93 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9-13 years (x3); No
HepB birth; Yes health workers and seafarers
IPV Yes From January 2015
MR 12 months; 6 years; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus Yes From 2015
TT 13 years; Yes
Td Yes From 2016
VitaminA 6-12 months; 13 months to 6 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2015  2013-2017  2008-2012  2008-2012  2008-2012     
Nº of districts with microplans that include activities to raise immunization coverage number    

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  Yes       

System performance

Total Nº districts in country number 24 
Nº districts with DTP3 coverage >=80% number 11 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  83  83  46  33 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 50  17  17  33     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100    111    100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.